InMed Pharmaceuticals's chart data is dated 2026-10-09. There is no active technical signal. There are 0 published signal records.
InMed Pharmaceuticals last closed at $1.36 (+2.26%) on 2026-10-09. Listed on Nasdaq. Trailing 12 months PER is -0.5×. Its overall grade ranks 597 of 738 stocks in Healthcare.
About this company
InMed Pharmaceuticals last closed at $1.36 (+2.26%) on 2026-10-09. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall D · 597/738
Valuation grade C+
Related stocks
- Jazz PharmaceuticalsCompetitor
칸나비노이드·희귀질환 치료제 개발에서 경쟁 가능성이 있는 바이오 제약사
- GW PharmaceuticalsCompetitor
의료용 대마 기반 의약품 분야의 대표 경쟁사(현재 Jazz에 인수됨)
- Cara TherapeuticsCompetitor
가려움증·진통 등 바이오 신약 개발에서 소형 바이오 경쟁사로 비교되는 사례
About InMed Pharmaceuticals
- What technical signals does InMed Pharmaceuticals (INM) have?
- InMed Pharmaceuticals current technical signals: no active technical signal.
- Is InMed Pharmaceuticals a cup-and-handle pattern?
- No. InMed Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for InMed Pharmaceuticals?
- Market cap: $3.81M. Trailing 12 months PER: -0.5×. Latest quarter PBR: 5.41×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about InMed Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.